The company was named one of 8 super finalists in the global health technology competition identifying the most disruptive companies shaping the future of digital health.
CAMBRIDGE, Mass., November 8, 2022 /PRNewswire/ — Implicity®a leader in remote patient monitoring and cardiac data management solutions, announced that it has been selected to compete in the Health Tech Challengers (HTC) Super Finals to be held live at HLTH 2022.
The global competition identifies the best companies driving innovation in digital health. Implicity won the cardiovascular track and is one of eight startups invited to pitch in person at the live event at Vegas on November 15, 2 p.m. at the Venetian Ballroom D, Level 2where the final winner will be announced.
“We are honored to be part of such an impressive group of finalists. This recognition validates the positive impact our AI-powered platform is having on cardiologists and healthcare professionals caring for patients with CIED. .These remote heart monitoring solutions produce more and more data every year.The only way for clinicians to address it all is with AI-powered tools.We are proud to bring to the market a solution that can improve the daily lives of practitioners and allow them to spend more time with their patients,” said Dr. Arnaud Rosierelectrophysiologist, CEO and co-founder of Implicity.
Implicity’s AI algorithm that analyzes ECG data from implantable loop recorders (ILRs) received Food and Drug Administration clearance in late 2021. Earlier this year, the company announced $23M in a Series A financing to accelerate expansion in the United States and support the development of next-generation offerings that focus on heart disease prevention.
Health Tech Challenger finalists were selected by a panel of industry experts from top companies, venture capitalists, ecosystem builders and media partners. To learn more about the contest, visit: https://healthtechchallengers.com/#TOP8
Implicity® is a MedTech software company, co-founded by a cardiac electrophysiologist Arnaud Rosier MD, which provides a universal remote cardiac monitoring and research platform to clinics and service companies, helping them provide the best remote care for cardiac patients. Implicity develops unique AI- and knowledge-based algorithms with the potential to predict patient health status, reducing the workload of healthcare professionals.
The Implicity platform aggregates, normalizes and standardizes data from all implantable cardiac electronic devices from all major manufacturers and improves care for patients with chronic heart failure. Implicity proudly protects over 60,000 patients at 100 medical facilities across United States and Europa. For more information visit: www.implicity.com.